• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hansen Medical soars on FDA win for smaller robotic catheter

Hansen Medical soars on FDA win for smaller robotic catheter

February 11, 2014 By Arezu Sarvestani

Hansen Medical lands FDA win for smaller robotic catheter

California surgical robotics maker Hansen Medical (NSDQ:HNSN) won FDA clearance for a smaller version of its Magellan catheter for use in peripheral vascular interventions.

HNSN stock soared on the news, rising 20.2% to $2.68 as of about 12:40 p.m. today.

The FDA win trigged the mandatory exercise of $14 million in Series A warrants that were issued in July 2013 in a private placement funding round, Hansen reported. The company further issued $11 million in Series B warrants priced at $1.50 apiece and Series C warrants at $2 apiece, both due in August 2015 and not subject to mandatory exercise.

Hansen’s Magellan catheters are part of the Magellan robotic surgery platform, which in June 2012 won FDA clearance for use during peripheral vascular interventions, providing navigation to anatomical targets and a conduit for manual device implantation while keeping physicians away from a potentially harmful radiation source.

The newly cleared Magellan 6Fr features 2 independent bend sites in a single catheter, compared with the 9Fr version’s use of 2 independently controlled catheters. Hansen initiated a limited launch of the 6Fr catheter, expecting to begin wider distribution later this year.

The Magellan system has applications for use by interventionalists, cardiologists, radiologists and endovascular surgeons, according to Hansen, and many of the centers performing peripheral vascular interventions today have also bought into Intuitive Surgical’s (NSDQ:ISRG) da Vinci robot-assisted surgery system.

Hansen has faced some recent legal turmoil amid an SEC investigation of former senior vice president Christopher Sells, accused of participating in a scheme to artificially inflate sales figures, and an $8.5 million settlement tied to a shareholder lawsuit over the company’s 2009 financial restatement.

Filed Under: Catheters, News Well, Regulatory/Compliance, Surgical Robotics Tagged With: Hansen Medical Inc.

More recent news

  • Former Intuitive sales leader joins surgical robot maker Virtual Incision as CEO
  • Smith+Nephew to open first orthopedic ambulatory surgery center in the UK
  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy